Effectiveness of transcranial direct current stimulant in Thai people with major depressive disorder : a randomized control trial

Not Applicable

Active, not recruiting

• Conditions: Major Depressive Disorder Non Response; transcranial direct current stimulant, major depressive disorder

• Registration Number: TCTR20180918003
• Lead Sponsor: Department of Mental Health, Ministry of Public Health, Thailand.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-09-18
• Study Completion: 2018-11-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

Thai people are not limited to sex 18 years old.
B. The Major Depressive Disorder diagnosis is based on DSM 5 diagnosis criteria by a psychiatrist.
The severity of depression in the lower level. Based on the HRSD-17 rating (8+)
Patients treated with antiarrhythmic drugs> 8 weeks and non-responders with HRSD-17> 17 or more. Remission Based on HRSD-17 scores over 8
Volunteer to join the project.

Exclusion Criteria

A physiologic illness that may be a barrier to treatment or response to treatment, such as a brain tumor, a skin cancer that can not be attached to the skin, a skull, a brain tumor, etc.
B. Female reproductive age who are planning to become pregnant or are pregnant or suspected to be pregnant.
High risk of suicide from 8Q> 17
D. Other psychiatric disorders such as schizophrenia, mood disorders. Alcohol use disorders and nicotine addiction.
Currently undergoing psychosocial rehabilitation programs, such as CBT, PST, IPT, Supportive Psychotherapy (SPT), Thai Traditional Massage Therapy (PMT)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
reduce depression After the treatment program ended 9Q ,reduce depression After the treatment program ended Hamilton Rating Scale for Depression (HRSD-17)

Secondary Outcome Measures

Name	Time	Method
remission rate After the treatment program ended 9Q ,remission rate After the treatment program ended Hamilton Rating Scale for Depression (HRSD-17),Quality of sleep After the treatment program ended The Pittsburgh Sleep Quality Index, PSQI,Quality of life After the treatment program ended EQ5D5L ,VAS